Rubric Capital Management (New York)’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,804,628
Closed -$27M 70
2024
Q4
$27M Buy
5,804,628
+1,124,600
+24% +$6.18M 0.35% 45
2024
Q3
$32.5M Buy
4,680,028
+943,226
+25% +$7.4M 0.53% 40
2024
Q2
$29.1M Buy
3,736,802
+1,619,748
+77% +$12M 0.76% 42
2024
Q1
$15M Sell
2,117,054
-3,755,752
-64% -$24.8M 0.44% 52
2023
Q4
$39.3M Buy
+5,872,806
New +$33.1M 0.82% 29

Other funds holding GDRX

Rubric Capital Management (New York)'s GDRX Position: Q1 2025 in Review

Rubric Capital Management (New York) sold out of GoodRx Holdings (GDRX) in Q1 2025, closing a stake of 5,804,628 shares — an estimated $27M sold.

Rubric Capital Management (New York) first reported a position in GDRX in Q4 2023 and held it in 5 quarters. The position peaked at $39.3M in Q4 2023. 170 funds tracked by Wall St. Rank hold GDRX as of Q1 2025.

  • Rubric Capital Management (New York) reported no remaining GoodRx Holdings position as of Q1 2025 after selling out during the quarter.
  • Rubric Capital Management (New York) sold 5,804,628 GoodRx Holdings shares in Q1 2025, an estimated $27M.
  • Rubric Capital Management (New York) first reported a position in GoodRx Holdings in Q4 2023 and held it in 5 quarters.
  • Rubric Capital Management (New York)'s GoodRx Holdings position peaked at $39.3M in Q4 2023.
  • 170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2025.

Based on Rubric Capital Management (New York)'s 13F filing for Q1 2025, filed 14 May 2025.